Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Podobne knjige/članki

• Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
  od: Issa, Amalia M., et al.
  Izdano: (2018)
• Taking Precise Aim at Lung Disease
  od: Piedimonte, Giovanni
  Izdano: (2019)
• FDA’s ‘Accelerated Approvals’ Are Critical But Raise Thorny Issues
  od: Miller, Henry I.
  Izdano: (2019)
• Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research
  od: Newman, Samantha Kass, et al.
  Izdano: (2015)
• The Accelerated Approval Debate: Faster FDA Drug Approvals May Mean Less Efficacy Data
  od: CARROLL, JOHN
  Izdano: (2012)